Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.
We've crossed a threshold: machines that appear to relate. The promise is real, but so is the risk of eroding human identity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results